Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Kronos Bio (KRON)
NASDAQ:KRON
Kronos Bio (KRON) Stock Price & Analysis
129 Followers
KRON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.20 - $5.74
Previous Close$1.69
Volume169.69K
Average Volume (3M)314.34K
Market Cap
$97.40M
Enterprise Value-$98.03M
Total Cash (Recent Filing)$226.40M
Total Debt (Recent Filing)$30.98M
Price to Earnings (P/E)-0.8
Beta1.48
Next Earnings
Aug 10, 2023EPS Estimate
-$0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.18
Shares Outstanding57,630,464
10 Day Avg. Volume213,207
30 Day Avg. Volume314,339
Standard Deviation0.18
R-Squared0.19
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.45
Price to Sales (P/S)81.16
Price to Cash Flow (P/CF)-4.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-81.69
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.80
Forecast
1Y Price Target
$10.50Price Target Upside521.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Kronos Bio News
Press ReleasesKronos Bio Announces Changes to Board of Directors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KRON FAQ
What was Kronos Bio’s price range in the past 12 months?
Kronos Bio lowest stock price was $1.20 and its highest was $5.74 in the past 12 months.
What is Kronos Bio’s market cap?
Currently, no data Available
When is Kronos Bio’s upcoming earnings report date?
Kronos Bio’s upcoming earnings report date is Aug 10, 2023 which is in 68 days.
How were Kronos Bio’s earnings last quarter?
Kronos Bio released its earnings results on May 10, 2023. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.445 by -$0.015.
Is Kronos Bio overvalued?
According to Wall Street analysts Kronos Bio’s price is currently Undervalued.
Does Kronos Bio pay dividends?
Kronos Bio does not currently pay dividends.
What is Kronos Bio’s EPS estimate?
Kronos Bio’s EPS estimate is -$0.48.
How many shares outstanding does Kronos Bio have?
Kronos Bio has 57,630,463 shares outstanding.
What happened to Kronos Bio’s price movement after its last earnings report?
Kronos Bio reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.445. Following the earnings report the stock price went down -2.762%.
Which hedge fund is a major shareholder of Kronos Bio?
Among the largest hedge funds holding Kronos Bio’s share is Omega Fund Management, LLC. It holds Kronos Bio’s shares valued at 6M.
---
Kronos Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.50 (521.30% Upside)
$10.50 (521.30% Upside)
Blogger Sentiment
Bullish
KRON Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 6.9%
Last 30 Days ▼ 6.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.01%
12-Months-Change
Fundamentals
Return on Equity
-45.40%
Trailing 12-Months
Asset Growth
-21.00%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Kronos Bio
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.
---
Top 5 ETFs holding KRON
Schwab U.S. Broad Market ETF
$47.87K
iShares Core S&P Total U.S. Stock Market ETF
$102.69
Up to five ETFs with an Outperform Smart Score that hold KRON. The ETFs are listed according to market value of KRON within the ETF
---
ImmunoCellular Therapeutics
―
Capricor Therapeutics
―
Praxis Precision Medicines
―
Peak Bio
―
Spero Therapeutics
―
---